Jerome L. Fleg

44.4k total citations · 13 hit papers
323 papers, 25.5k citations indexed

About

Jerome L. Fleg is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine and Surgery. According to data from OpenAlex, Jerome L. Fleg has authored 323 papers receiving a total of 25.5k indexed citations (citations by other indexed papers that have themselves been cited), including 242 papers in Cardiology and Cardiovascular Medicine, 91 papers in Complementary and alternative medicine and 60 papers in Surgery. Recurrent topics in Jerome L. Fleg's work include Cardiovascular Function and Risk Factors (96 papers), Cardiovascular and exercise physiology (91 papers) and Heart Failure Treatment and Management (66 papers). Jerome L. Fleg is often cited by papers focused on Cardiovascular Function and Risk Factors (96 papers), Cardiovascular and exercise physiology (91 papers) and Heart Failure Treatment and Management (66 papers). Jerome L. Fleg collaborates with scholars based in United States, Canada and Germany. Jerome L. Fleg's co-authors include Edward G. Lakatta, Ileana L. Piña, Gary Balady, Mark A. Williams, Jeanette G. Wright, Lewis C. Becker, Dalane W. Kitzman, Gary Gerstenblith, E. Jeffrey Metter and Laura A. Talbot and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Jerome L. Fleg

316 papers receiving 24.3k citations

Hit Papers

Efficacy and Safety of Exercise Tr... 1984 2026 1998 2012 2009 2013 2001 1993 2000 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure
    2009 1.4k citations Christopher M. O’Connor, David J. Whellan et al. profile →
  2. Exercise Standards for Testing and Training
    2013 1.4k citations Gerald F. Fletcher, Philip A. Ades et al. Circulation profile →
  3. Exercise Standards for Testing and Training
    2001 1.4k citations Gerald F. Fletcher, Gary Balady et al. Circulation profile →
  4. Effects of age and aerobic capacity on arterial stiffness in healthy adults.
    1993 833 citations Jerome L. Fleg, Jeanette G. Wright et al. Circulation profile →
  5. Resistance Exercise in Individuals With and Without Cardiovascular Disease
    2000 783 citations Gary Balady, Jerome L. Fleg et al. Circulation profile →
  6. Exercise and Heart Failure
    2003 754 citations Ileana L. Piña, Gary Balady et al. Circulation profile →
  7. Accelerated Longitudinal Decline of Aerobic Capacity in Healthy Older Adults
    2005 686 citations Jerome L. Fleg, Christopher H. Morrell et al. Circulation profile →
  8. Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate.
    1984 476 citations Gary Gerstenblith, Lewis C. Becker et al. Circulation profile →
  9. Role of muscle loss in the age-associated reduction in VO2 max
    1988 472 citations Jerome L. Fleg, Edward G. Lakatta profile →
  10. ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly
    2011 406 citations Wilbert S. Aronow, Jerome L. Fleg et al. Circulation profile →
  11. High-Risk Plaque Detected on Coronary CT Angiography Predicts Acute Coronary Syndromes Independent of Significant Stenosis in Acute Chest Pain
    2014 362 citations Jerome L. Fleg et al. Journal of the American College of Cardiology profile →
  12. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
    2015 335 citations Scott D. Solomon, Eldrin F. Lewis et al. profile →
  13. Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology
    2023 69 citations Steven J. Keteyian, Jerome L. Fleg et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerome L. Fleg United States 78 16.5k 7.0k 4.3k 3.2k 2.5k 323 25.5k
Gary Balady United States 59 16.6k 1.0× 8.6k 1.2× 3.8k 0.9× 2.5k 0.8× 3.5k 1.4× 121 24.3k
Ileana L. Piña United States 79 19.6k 1.2× 5.4k 0.8× 2.4k 0.6× 2.9k 0.9× 1.6k 0.6× 351 27.0k
Jonathan Myers United States 80 20.6k 1.2× 15.8k 2.2× 6.8k 1.6× 2.8k 0.9× 1.7k 0.7× 621 31.4k
Gerald F. Fletcher United States 42 10.9k 0.7× 5.9k 0.8× 3.0k 0.7× 2.0k 0.6× 2.5k 1.0× 135 17.4k
Robert Fagard Belgium 75 23.9k 1.4× 4.3k 0.6× 3.5k 0.8× 4.5k 1.4× 1.1k 0.5× 489 33.0k
Ross Arena United States 80 21.0k 1.3× 14.0k 2.0× 7.9k 1.8× 2.9k 0.9× 1.5k 0.6× 708 38.3k
Dalane W. Kitzman United States 97 27.5k 1.7× 7.2k 1.0× 4.3k 1.0× 3.3k 1.0× 4.1k 1.6× 490 35.8k
Richard V. Milani United States 72 11.2k 0.7× 3.7k 0.5× 3.6k 0.8× 2.3k 0.7× 1.5k 0.6× 294 18.9k
Massimo Piepoli Italy 74 16.6k 1.0× 6.6k 0.9× 1.9k 0.4× 2.3k 0.7× 1.6k 0.6× 349 21.6k
Philip A. Ades United States 60 10.9k 0.7× 5.0k 0.7× 3.8k 0.9× 1.4k 0.4× 1.4k 0.6× 213 17.3k

Countries citing papers authored by Jerome L. Fleg

Since Specialization
Citations

This map shows the geographic impact of Jerome L. Fleg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome L. Fleg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome L. Fleg more than expected).

Fields of papers citing papers by Jerome L. Fleg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome L. Fleg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome L. Fleg. The network helps show where Jerome L. Fleg may publish in the future.

Co-authorship network of co-authors of Jerome L. Fleg

This figure shows the co-authorship network connecting the top 25 collaborators of Jerome L. Fleg. A scholar is included among the top collaborators of Jerome L. Fleg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerome L. Fleg. Jerome L. Fleg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hausvater, Anaïs, Rebecca Anthopolos, Tanya M. Spruill, et al.. (2025). Sex Differences in Psychosocial Factors and Angina in Patients With Chronic Coronary Disease. Journal of the American Heart Association. 14(5). e037909–e037909. 1 indexed citations
2.
AlGhatrif, Majd, Christopher H. Morrell, Jerome L. Fleg, et al.. (2024). Longitudinal decline in peak Vo2 with aging in a healthy population is associated with a reduction in peripheral oxygen utilization but not in cardiac output. American Journal of Physiology-Heart and Circulatory Physiology. 327(2). H509–H517.
3.
Keteyian, Steven J., Joseph Finkelstein, Daniel E. Forman, et al.. (2023). Baseline Characteristics and Barriers to Recruitment in Cardiac and Pulmonary Rehabilitation NIH-Funded Trials. Journal of Cardiopulmonary Rehabilitation and Prevention. 43(6). 407–411. 2 indexed citations
4.
Briguori, Carlo, Roy O. Mathew, Zhen Huang, et al.. (2022). Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA‐CKD. Journal of the American Heart Association. 11(6). e022003–e022003. 6 indexed citations
5.
Mathew, Roy O., David J. Maron, Rebecca Anthopolos, et al.. (2022). Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial. Circulation Cardiovascular Quality and Outcomes. 15(10). 6 indexed citations
6.
Shero, Susan T., Lawton S. Cooper, Joseph Finkelstein, et al.. (2021). Update on RFA Increasing Use of Cardiac and Pulmonary Rehabilitation in Traditional and Community Settings NIH-Funded Trials. Journal of Cardiopulmonary Rehabilitation and Prevention. 42(1). 10–14. 7 indexed citations
7.
Fleg, Jerome L., Steven J. Keteyian, Pamela N. Peterson, et al.. (2020). Increasing Use of Cardiac and Pulmonary Rehabilitation in Traditional and Community Settings. Journal of Cardiopulmonary Rehabilitation and Prevention. 40(6). 350–355. 19 indexed citations
8.
Parikh, Kishan S., Adrian Coles, Phillip J. Schulte, et al.. (2016). Relation of Angina Pectoris to Outcomes, Quality of Life, and Response to Exercise Training in Patients With Chronic Heart Failure (from HF-ACTION). The American Journal of Cardiology. 118(8). 1211–1216. 12 indexed citations
9.
Joseph, Jacob, Brian Claggett, Inder S. Anand, et al.. (2016). QRS Duration Is a Predictor of Adverse Outcomes in Heart Failure With Preserved Ejection Fraction. JACC Heart Failure. 4(6). 477–486. 36 indexed citations
10.
Fletcher, Gerald F., Philip A. Ades, Paul Kligfield, et al.. (2013). Exercise Standards for Testing and Training. Circulation. 128(8). 873–934. 1412 indexed citations breakdown →
11.
Fleg, Jerome L., Gregg W. Stone, Zahi A. Fayad, et al.. (2012). Detection of High-Risk Atherosclerotic Plaque. JACC. Cardiovascular imaging. 5(9). 941–955. 165 indexed citations
12.
Barzilay, Joshua I., Annie Green Howard, Gregory W. Evans, et al.. (2012). Intensive Blood Pressure Treatment Does Not Improve Cardiovascular Outcomes in Centrally Obese Hypertensive Individuals With Diabetes. Diabetes Care. 35(7). 1401–1405. 21 indexed citations
13.
Fleg, Jerome L., Wilbert S. Aronow, & William H. Frishman. (2010). Cardiovascular drug therapy in the elderly: benefits and challenges. Nature Reviews Cardiology. 8(1). 13–28. 128 indexed citations
14.
Pop‐Busui, Rodica, Gregory W. Evans, Hertzel C. Gerstein, et al.. (2010). Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. Diabetes Care. 33(7). 1578–1584. 349 indexed citations
15.
Howard, Barbara V., Mary J. Roman, Richard B. Devereux, et al.. (2008). Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial. Obstetrical & Gynecological Survey. 63(8). 512–513. 13 indexed citations
16.
Najjar, Samer S., Angelo Scuteri, Veena Shetty, et al.. (2008). Pulse Wave Velocity Is an Independent Predictor of the Longitudinal Increase in Systolic Blood Pressure and of Incident Hypertension in the Baltimore Longitudinal Study of Aging. Journal of the American College of Cardiology. 51(14). 1377–1383. 376 indexed citations
17.
Ginsberg, Henry N., Denise E. Bonds, Laura Lovato, et al.. (2007). Evolution of the Lipid Trial Protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. The American Journal of Cardiology. 99(12). S56–S67. 73 indexed citations
18.
Ahmed, Ali, Michael W. Rich, Jerome L. Fleg, et al.. (2006). Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure. Circulation. 114(5). 397–403. 420 indexed citations
19.
Harik-Khan, Raida, Jerome L. Fleg, Denis C. Muller, & Robert A. Wise. (2001). The Effect of Anthropometric and Socioeconomic Factors on the Racial Difference in Lung Function. American Journal of Respiratory and Critical Care Medicine. 164(9). 1647–1654. 108 indexed citations
20.
Contoreggi, Carlo, Marc R. Blackman, Reubin Andres, et al.. (1990). Plasma Levels of Estradiol, Testosterone, and DHEAS Do Not Predict Risk of Coronary Artery Disease in Men. Journal of Andrology. 11(5). 460–470. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gary Balady Breakdown of academic impact, for papers by Ileana L. Piña Breakdown of academic impact, for papers by Jonathan Myers Breakdown of academic impact, for papers by Gerald F. Fletcher Breakdown of academic impact, for papers by Robert Fagard Breakdown of academic impact, for papers by Ross Arena Breakdown of academic impact, for papers by Dalane W. Kitzman Breakdown of academic impact, for papers by Richard V. Milani Breakdown of academic impact, for papers by Massimo Piepoli Breakdown of academic impact, for papers by Philip A. Ades
Rankless by CCL
2026